BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33674267)

  • 1. Use of social impact bonds in financing health systems responses to non-communicable diseases: scoping review.
    Hulse ESG; Atun R; McPake B; Lee JT
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33674267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-Based Analysis of Social Impact Bonds for Homelessness: A Scoping Review.
    Wang H; Xu X
    Front Psychol; 2022; 13():823390. PubMed ID: 35795436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of frameworks demonstrating the role of private sector in non-communicable disease management and control: a systematic review and thematic synthesis.
    Somani NA; Marshall K; Durrani H; Tang K; Mogilevskii R; Bhutta Z
    BMJ Open; 2023 Mar; 13(3):e061370. PubMed ID: 36868600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; KeskinkiliƧ B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financing national non-communicable disease responses.
    Allen LN
    Glob Health Action; 2017; 10(1):1326687. PubMed ID: 28604238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social Impact Bonds as a Funding Method for Health and Social Programs: Potential Areas of Concern.
    Katz AS; Brisbois B; Zerger S; Hwang SW
    Am J Public Health; 2018 Feb; 108(2):210-215. PubMed ID: 29267055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framing global discourses on non-communicable diseases: a scoping review.
    Tan MMJ; Han E; Shrestha P; Wu S; Shiraz F; Koh GC; McKee M; Legido-Quigley H
    BMC Health Serv Res; 2021 Jan; 21(1):20. PubMed ID: 33407447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of non-communicable diseases among Syrian refugees: a scoping review.
    Naja F; Shatila H; El Koussa M; Meho L; Ghandour L; Saleh S
    BMC Public Health; 2019 May; 19(1):637. PubMed ID: 31126261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world data for precision public health of noncommunicable diseases: a scoping review.
    Canfell OJ; Kodiyattu Z; Eakin E; Burton-Jones A; Wong I; Macaulay C; Sullivan C
    BMC Public Health; 2022 Nov; 22(1):2166. PubMed ID: 36434553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges of global health diplomacy for prevention and control of noncommunicable diseases: a systematic review.
    Asadi-Lari M; Ahmadi Teymourlouy A; Maleki M; Afshari M
    BMC Health Serv Res; 2021 Nov; 21(1):1193. PubMed ID: 34736461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Health diplomacy for noncommunicable diseases prevention and control: a systematic review.
    Afshari M; Ahmadi Teymourlouy A; Asadi-Lari M; Maleki M
    Global Health; 2020 May; 16(1):41. PubMed ID: 32375804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
    Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
    PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
    Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
    BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of governance of noncommunicable diseases (NCDs) in West African countries.
    Ouedraogo M; Sanou D; Ouedraogo O; Zongo U; Hama-Ba F; Savadogo A
    Pan Afr Med J; 2023; 44():203. PubMed ID: 37484591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses.
    Marshall K; Beaden P; Durrani H; Tang K; Mogilevskii R; Bhutta Z
    Int J Qual Stud Health Well-being; 2023 Dec; 18(1):2156099. PubMed ID: 36591948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on Noncommunicable Diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India.
    Kundu MK; Hazra S; Pal D; Bhattacharya M
    Indian J Public Health; 2018; 62(4):302-304. PubMed ID: 30539894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care providers' perspectives of diet-related non-communicable disease in South Africa.
    Hunter-Adams J; Battersby J
    BMC Public Health; 2020 Feb; 20(1):262. PubMed ID: 32085725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demand-side financing measures to increase maternal health service utilisation and improve health outcomes: a systematic review of evidence from low- and middle-income countries.
    Murray SF; Hunter BM; Bisht R; Ensor T; Bick D
    JBI Libr Syst Rev; 2012; 10(58):4165-4567. PubMed ID: 27820523
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.